Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Genes, Chromosomes & Cancer|September 30, 2009
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effortLaura Ottaviano, Karl-Ludwig Schaefer, Melanie Gajewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) TrialsEmanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Cancer Epidemiology|August 18, 2023
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcomaD Matthew Gianferante, Amy Moore, Logan G Spector, et al.
International Journal of Cancer|December 7, 2017
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patientsRoelof Koster, Orestis A Panagiotou, William A Wheeler, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Micro-invasive, off-pump, trans-ventricular neochordae implantation in recurrent mitral valve regurgitation after open heart surgical repairStefano Salizzoni, Rashmi Yadav, Peyman Sardari Nia, et al.
Journal of the National Cancer Institute|September 25, 2025
SMARCAL1 is a new osteosarcoma predisposition geneMaryam Rafati, Lillian M Guenther, Laura E Egolf, et al.
JAMA Oncology|March 20, 2020
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaLisa Mirabello, Bin Zhu, Roelof Koster, et al.
Nature Genetics|June 4, 2013
Genome-wide association study identifies two susceptibility loci for osteosarcomaSharon A Savage, Lisa Mirabello, Zhaoming Wang, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Genes, Chromosomes & Cancer|September 30, 2009
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effortLaura Ottaviano, Karl-Ludwig Schaefer, Melanie Gajewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) TrialsEmanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Cancer Epidemiology|August 18, 2023
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcomaD Matthew Gianferante, Amy Moore, Logan G Spector, et al.
International Journal of Cancer|December 7, 2017
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patientsRoelof Koster, Orestis A Panagiotou, William A Wheeler, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Micro-invasive, off-pump, trans-ventricular neochordae implantation in recurrent mitral valve regurgitation after open heart surgical repairStefano Salizzoni, Rashmi Yadav, Peyman Sardari Nia, et al.
Journal of the National Cancer Institute|September 25, 2025
SMARCAL1 is a new osteosarcoma predisposition geneMaryam Rafati, Lillian M Guenther, Laura E Egolf, et al.
JAMA Oncology|March 20, 2020
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaLisa Mirabello, Bin Zhu, Roelof Koster, et al.
Nature Genetics|June 4, 2013
Genome-wide association study identifies two susceptibility loci for osteosarcomaSharon A Savage, Lisa Mirabello, Zhaoming Wang, et al.
Pageof 16